Dr Whitney Goldsberry on Cost-Sharing Trends in PARP Inhibitors for Ovarian Cancer
February 6th 2021, 5:00am
VideoWhitney Goldsberry, MD, fellow at the University of Alabama's Division of Gynecologic Oncology, discusses findings from her and colleagues' recent analysis of cost-sharing trends for PARP inhibitors in ovarian cancer treatment.